RO103682A2 - Isolation method of human ceruloplasmin - Google Patents
Isolation method of human ceruloplasminInfo
- Publication number
- RO103682A2 RO103682A2 RO13784989A RO13784989A RO103682A2 RO 103682 A2 RO103682 A2 RO 103682A2 RO 13784989 A RO13784989 A RO 13784989A RO 13784989 A RO13784989 A RO 13784989A RO 103682 A2 RO103682 A2 RO 103682A2
- Authority
- RO
- Romania
- Prior art keywords
- isolation method
- human ceruloplasmin
- human
- ceruloplasmin
- imcuso4
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Sera or human plasma is treated with a soln. of IMCuSO4 (100:0.4) and maintained at 68 deg.C for 30 mins. centrifuged, chromatographed over DEAE-sepharose Cl-68 using 0.02M Napyrophosphate and acetic acid, at pH 7.5 and the Cibacron-Blue F3GA-Biogel A5m with 0.05M TFS at pH7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO137849A RO103682B1 (en) | 1989-01-20 | 1989-01-20 | Isolation method of human ceruloplasmin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RO137849A RO103682B1 (en) | 1989-01-20 | 1989-01-20 | Isolation method of human ceruloplasmin |
Publications (2)
Publication Number | Publication Date |
---|---|
RO103682A2 true RO103682A2 (en) | 1991-12-09 |
RO103682B1 RO103682B1 (en) | 1992-03-26 |
Family
ID=20123823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RO137849A RO103682B1 (en) | 1989-01-20 | 1989-01-20 | Isolation method of human ceruloplasmin |
Country Status (1)
Country | Link |
---|---|
RO (1) | RO103682B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1232251A4 (en) * | 1999-11-13 | 2004-09-01 | Bayer Healthcare Llc | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6964764B2 (en) | 1999-11-13 | 2005-11-15 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6969515B2 (en) | 1999-11-13 | 2005-11-29 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US7544500B2 (en) | 1999-11-13 | 2009-06-09 | Talecris Biotherapeutics, Inc. | Process for the production of a reversibly inactive acidified plasmin composition |
US8617863B2 (en) | 2008-06-04 | 2013-12-31 | Grifols Therapeutics Inc. | Composition, method, and kit for preparing plasmin |
-
1989
- 1989-01-20 RO RO137849A patent/RO103682B1/en unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1232251A4 (en) * | 1999-11-13 | 2004-09-01 | Bayer Healthcare Llc | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6964764B2 (en) | 1999-11-13 | 2005-11-15 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6969515B2 (en) | 1999-11-13 | 2005-11-29 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US7544500B2 (en) | 1999-11-13 | 2009-06-09 | Talecris Biotherapeutics, Inc. | Process for the production of a reversibly inactive acidified plasmin composition |
US7871608B2 (en) | 1999-11-13 | 2011-01-18 | Talecris Biotherapeutics, Inc. | Reversibly inactivated acidified plasmin |
EP1232251B2 (en) † | 1999-11-13 | 2017-05-17 | Grifols Therapeutics Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US9879246B2 (en) | 1999-11-13 | 2018-01-30 | Grifols Therapeutics Inc. | Reversibly inactivated acidified plasmin composition |
US8617863B2 (en) | 2008-06-04 | 2013-12-31 | Grifols Therapeutics Inc. | Composition, method, and kit for preparing plasmin |
Also Published As
Publication number | Publication date |
---|---|
RO103682B1 (en) | 1992-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1591529A3 (en) | Human CLTA-8 and uses of CTLA-8-related proteins | |
WO1990013306A3 (en) | Small polypeptides | |
EP0875563A3 (en) | Improved methods for processing activated protein C | |
NO981079L (en) | Bacterial repellent and blood compatible modified surfaces | |
AU2710188A (en) | Enzymatic treatment of wool | |
AU6518890A (en) | 6-amino-1,2-benzopyrones useful for treatment of viral diseases | |
AU7527987A (en) | A method for the prevention of fusarium diseases and microorganisms used for the same | |
WO1990012879A3 (en) | Expression of human apolipoproteins ai-milano in yeast | |
AU3413389A (en) | Method of treating retrovirus infection | |
RO103682A2 (en) | Isolation method of human ceruloplasmin | |
AU561222B2 (en) | Process for the pasteurization of human plasma | |
AU4090289A (en) | Method for the treatment of wool | |
NO180181C (en) | Process for the preparation of an ice-nucleating protein, plasmids and bacterial strains | |
AU617187B2 (en) | Treatment of aqueous dispersions | |
AU2659088A (en) | Method for the treatment of anxiety | |
AU582303B2 (en) | Method of curve approximation | |
OA08402A (en) | Method for the treatment of natural rubber field latex. | |
AU6885287A (en) | Gas treatment process | |
AU578079B2 (en) | A method for the treatment of glaucoma | |
EP0333020A3 (en) | Process for the preparation of substituted pyridines | |
AU8312787A (en) | Method for controlling the semiconductor switches of a rectifier bridge connected to an a.c. mains supply, and a control unit designed for applying the method | |
IL115826A0 (en) | Use of erythropoietin in the treatment of rheumatoid arthritis | |
AU8013587A (en) | A method and composition for the treatment of bathtubs | |
AU7438900A (en) | Recombinant antigen of taenia solium metacestodes | |
AU5240886A (en) | Sulphonyldihydropyridines for treatment of asthma |